US FDA approves Asahi Kasei's drug for persistent herpes infections

The US FDA on Friday approved Japan's Asahi Kasei's ​drug for persistent herpes simplex virus sores in certain patients with weakened immune systems who have ‌not responded to available antiviral treatments.

Health Rounds: Blindness treatment based on Nobel-winning research shows promise

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)

Teva wins FDA approval for monthly schizophrenia injection Weltruza

(Corrects sourcing in bullet 3, updates share reaction in ​bullet point 5)